Because of the potential hazards of phototherapy, we have explored the feasibility of reducing total light dosage without impairing effectiveness. We have compared intermittent and continuous phototherapy in treating nonhemolytic “physiological” hyperbilirubinemia. Premature infants (n=76) weighing between 1200-2400 gm whose serum bilirubin concentration (SBC) exceeded 8 mg/dl within the first 3 days of life were included in the study. Patients were randomly assigned to one of four treatment groups: (a) continuous light (control, n=26), (b) 15 minutes light on, 15 minutes light off (n=16), (c) 15 min. on, 30 min. off (n=17),(d) 15 min. on, 60 min. off (n=17). Phototherapy was discontinued when the S.B.C. was 8 mg/dl or lets on two consecutive measurements. The total light dosage received by the study groups was (b) 49%, (c) 42%, (d) 28% of the exposure of control (a) infants. There was no statistically significant difference between the study groups and the control in the duration of phototherapy, the peak S.B.C. arid the time from the start of therapy to the peak value. There were no significant differences in the number of infants in each group whose peak S.B.C. exceeded 10 mg/dl and 12 mg/dl. Thus, intermittent phototherapy with the described time schedules (resulting in a reduction of total light dosage of up to 72%) is as effective as continuous phototherapy in the treatment of hyperbilirubinemia in the premature infant.